Breaking
FDA to rule on Novo’s CagriSema soonAI Raises Concerns in Healthcare SystemsFDA approves new hepatitis B treatmentFDA Approves Tildrakizumab for Psoriatic ArthritisTenet boosts earnings with focus on high-value surgeriesAI Models Often Give Wrong Medication Doses

cagrisema

FDA to rule on Novo’s CagriSema soon
Clinic Briefs

FDA to rule on Novo’s CagriSema soon

The U.S. Food and Drug Administration is expected to issue its decision before the close of 2026 on whether to grant approval…

Zenobia Fairweather · November 6, 2026